These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2414987)

  • 1. Multimodality therapy for unresectable squamous cell carcinoma of the head and neck.
    Perry DJ; Davis RK; Duttenhaver JR; Zajtchuk JT; Hauck KH; Major WB; Baumann JC
    Am J Clin Oncol; 1985 Oct; 8(5):380-3. PubMed ID: 2414987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-containing chemotherapy in advanced head and neck cancer.
    Paterson IC; Quilty PM
    Clin Radiol; 1985 Nov; 36(6):607-10. PubMed ID: 2415291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients.
    Benasso M; Bonelli L; Numico G; Corvò R; Sanguineti G; Rosso R; Vitale V; Merlano M
    Ann Oncol; 1997 Aug; 8(8):773-9. PubMed ID: 9332685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer.
    Stolwijk C; Wagener DJ; Van den Broek P; Levendag PC; Kazem I; Bruaset I; De Mulder PH
    Neth J Med; 1985; 28(9):347-51. PubMed ID: 2413379
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential chemo-radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Wendt TG; Chucholowski M; Hartenstein R; Rohloff R; Willich N
    Int J Radiat Oncol Biol Phys; 1986 Mar; 12(3):397-9. PubMed ID: 2420771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation.
    Poole ME; Sailer SL; Rosenman JG; Tepper JE; Weissler MC; Shockley WW; Yarbrough WG; Pillsbury HC; Schell MJ; Bernard SA
    Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1446-50. PubMed ID: 11735812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.
    Merlano M; Vitale V; Rosso R; Benasso M; Corvò R; Cavallari M; Sanguineti G; Bacigalupo A; Badellino F; Margarino G
    N Engl J Med; 1992 Oct; 327(16):1115-21. PubMed ID: 1302472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
    Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
    Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.
    Vogl SE; Komisar A; Kaplan BH; Engstrom PF; Kasule OH; Stolbach L; Lerner H; Muggia F
    Cancer; 1986 Feb; 57(4):706-10. PubMed ID: 2417680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermochemotherapy in inoperable head and neck cancer.
    Davis RK; Gibbs FA; Sapozink MD; Farver M; Harker G
    Otolaryngol Head Neck Surg; 1990 Dec; 103(6):897-901. PubMed ID: 2126122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy prior to definitive local therapy in squamous cell carcinoma of the head and neck.
    Adelstein DJ; Hines JD; Sharan VM; Streeter RR; Earle AS; Haria CD; Carter SG; Shah AC; Vlastou C; Damm C
    Oncology; 1985; 42(2):80-5. PubMed ID: 2581202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
    Ervin TJ; Clark JR; Weichselbaum RR; Fallon BG; Miller D; Fabian RL; Posner MR; Norris CM; Tuttle SA; Schoenfeld DA
    J Clin Oncol; 1987 Jan; 5(1):10-20. PubMed ID: 2433406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
    Iop A; Cartei G; Isaia A
    Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.